MarketScale Transportation 01/29/19: Will Tariffs or Technology Be the Year’s Biggest Disruptor?

 

On this episode of the MarketScale Transportation Podcast, we wanted to pose the question: what will be the biggest disruptor of the transportation industry in 2019? Before we can get a feel for that main question, we have to take a look at where companies are investing their time and effort. Uber’s JUMP program is another indication that big transportation disruptors are looking to disrupt a little more. In this feature, we’re joined by Dr. Susan Shaheen from the UC Berkeley Transportation Sustainability Research Center to explain what Uber’s further immersion to the micromobility space means for the industry.

Also on this week’s show, Dr. Dave Tuttle, Research Fellow in the Energy Institute at University of Texas at Austin, joins to give his insight on the main disrupters for the transportation industry in 2019. With technology and tariffs both threatening to play a big part moving forward, Tuttle discusses the real challenge that tariffs pose to automakers, the other factors causing uncertainty in the industry, and what he would fix if he were the boss of everybody in the industry for a day.

Micromobility with Dr. Susan Shaheen

On this episode we’re joined by Dr. Susan Shaheen from the UC Berkeley Transportation Sustainability Research Center. The center focuses on studying the economic, social, environmental, and technological aspects of sustainable transportation. Susan is going to help us understand why exactly her kind of research matters, how it can affect policy making, and why Micromobility has been on the rise. In addition, we also pick her brain about different shifts in the industry like bike-sharing, escooters, and Uber’s dominance in the sector.

Tariffs vs. Tech: Transportations Uncertain 2019

News cycles have a tendency to capture our attention. One of the latest items to garner views is the imposition of tariffs and how they will affect the automotive industry in the U.S. On today’s podcast, I have the chance to chat with Dr. Dave Tuttle from the University of Texas at Austin. We discuss the real challenge that tariffs pose to automakers, the other factors causing uncertainty in the industry, and some things he would fix if he were the boss of everybody for a day.

For the latest news, videos, and podcasts in the Transportation Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @TransportMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More